期刊文献+

糖基化终产物对凝集素样氧化型低密度脂蛋白受体1表达的影响 被引量:2

Effect of Advanced Glycation End Products on Expression of Lectin-Like Oxidized Low Density Lipoprotein Receptor-1
暂未订购
导出
摘要 目的研究长期高血糖所致糖基化终产物对巨噬细胞凝集素样氧化型低密度脂蛋白受体1表达的影响。方法 U937细胞经佛波酯诱导分化,并将不同浓度或同一浓度糖基化终产物与诱导分化48 h后的U937细胞共同孵育,用Western Blotting法检测凝集素样氧化型低密度脂蛋白受体1蛋白的表达。同时应用ELISA法测定24例2型糖尿病患者及22例正常对照者血清可溶性氧化型低密度脂蛋白受体1的含量。结果 100、200和400 mg/L糖基化终产物刺激后细胞表面凝集素样氧化型低密度脂蛋白受体1蛋白表达量分别是对照组的1.85、3.22和4.65倍(P<0.05);400 mg/L的糖基化终产物作用12、24、48 h后,U937巨噬细胞该受体蛋白表达量分别为0 h的2.85、3.89和4.3倍(P<0.05)。糖尿病患者血清氧化型低密度脂蛋白受体1及糖基化终产物含量较正常对照者显著升高(P<0.01),两者呈正相关(P<0.001)。结论糖基化终产物可增加U937巨噬细胞凝集素样氧化型低密度脂蛋白受体1蛋白表达且呈浓度和时间依赖性。这可能与糖尿病患者加速泡沫细胞形成而易致动脉粥样硬化有关。 Aim To learn the effects of advanced glycation end products(AGE) on expression of lectin-like oxidized low density lipoprotein(LOX-1) protein in U937 macrophages and serum soluble LOX-1(sLOX-1). Methods U937 macrophages differentiating for 48 h were incubated with AGE in various concentrations and time.The expression of LOX-1 protein were detected by Western Blotting analysis.Serum sLOX-1 and AGE levels were detected by ELISA in 24 diabetes and 22 normal controls. Results After exposure of U937 macrophages to 100,200 or 400 mg/L AGE,the expression of LOX-1 protein was 1.85-,3.22-and 4.65-fold,as compared with that of control group(P0.05),LOX-1 protein expression following 400 mg/L AGE for 12,24,48 h was 2.85-,3.89-and 4.3-fold compared with 0 h group(P0.05).Serum sLOX-1 and AGE levels were significantly increased in diabetes group compared with that of control(P0.01).They were positively correlated(P0.001). Conclusion AGE could enhance the expression of LOX-1 protein in a time-and dose-dependent manner,which may play an important role in diabetic macroangiopathy through accelerating foam cell formation.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2010年第7期559-562,共4页 Chinese Journal of Arteriosclerosis
关键词 糖基化终产物 巨噬细胞 凝集素样氧化型低密度脂蛋白受体 动脉粥样硬化 Advanced Glycation End Products Macrophages Lectin-Like Oxidized Low Density Lipoprotein Receptor Atherosclerosis
  • 相关文献

参考文献12

  • 1Liu J, Grundy SM, Wang W, et al. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome [J]. Am Heart J, 2007, 153 (4) : 552-558.
  • 2Hanna-Moussa A, Gardner M J, Kurukulasuriya LR, et al. Dysglycemia/ prediabetes and cardiovascular risk factors [ J ]. Rev Cardiovasc Med, 2009, 10 (4) : 202-208.
  • 3Murase T, Kume N, Korenaga R, et al. Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells [J]. Circ Res, 1998, 83 (3) : 328-333.
  • 4Kume N, Moriwaki H, Kataoka H, et al. Inducible expression of LOX-1, a novel receptor for oxidized LDL, in macrophages and vascular smooth muscle cells [ J ]. Ann N Y Acad Sci, 2000, 902 (5) : 323 -327.
  • 5Moriwaki H, Kume N, Kataoka H, et al. Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: upregulated expression by TNF-alpha [ J ]. FEBS Lett, 1998, 440 ( 1- 2) : 29-32.
  • 6Li L, Roumeliotis N, Sawamura T, et al. C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction [ J ]. Circ Res, 2004, 95 (9) : 877-883.
  • 7Li D, Liu L, Chert H, et al. LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells [J]. Circulation, 2003, 107 (4) : 612-617.
  • 8尹凯,涂玉林,桂庆军.凝集素样氧化型低密度脂蛋白受体1与动脉粥样硬化易损斑块[J].中国动脉硬化杂志,2008,16(7):572-574. 被引量:6
  • 9陈锋,张振东,唐新华.氧化型低密度脂蛋白对平滑肌祖细胞增殖和表型的影响[J].中国动脉硬化杂志,2009,17(9):723-726. 被引量:3
  • 10Ohgami N, Nagai R, Ikemoto M, et al. CD36, a member of the class B scavenger receptor family, as a receptor for advanced glycation end products [ J]. J Biol Chem, 2001,276 (5): 3 195-202.

二级参考文献44

  • 1张峻,陈纪林,顾晴,关婷,陈曦.阻断CD40-CD40配体系统对动脉粥样硬化的影响[J].中国动脉硬化杂志,2006,14(2):119-122. 被引量:18
  • 2Simper D, Stalboerger PG, Panetta C J, et al. Smooth muscle progenitor cells in human blood [J]. Circulation, 2002, 106 (10) : 1 199-204.
  • 3Sata M. Circulating vascular progenitor cells contribute to vascular repair, remodeling, and lesion formation [ J ]. Trends Cardiovasc Med, 2003, 13 (6) : 249-253.
  • 4Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis [J]. Nat Med , 2002 , 8 ( 4 ) : 403 -409.
  • 5Zoll J, Fontaine Y, Gourdy P, et al. Role of human smooth muscle cell progenitors in atherosclerotic plaque development and composition [ J]. Cardiovasc Res, 2008, 77 (3) : 471-480.
  • 6Tanaka K, Sata M, Hirata Y, et al. Diverse contribution of bone marrow cells to neointlmal hyperplasia after mechanical vascular injuries [ J ]. Circ Res, 2003, 93 (8) : 783-790.
  • 7Caplice NM, Bunch TJ, Stalboerger PG, et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells adminlstered at marrow transplantation [ J ]. Proc Natl Acad Sci USA, 2003, 100 ( 8 ) : 4 754-759.
  • 8Han CI, Campbell GR, Campbell JH. Circulating bone marrow cells can contribute to neointimal formation [ J ]. J Vasc Res, 2001,38 (2) : 113- 119.
  • 9Hillebrands JL, Klatter FA, van-den-Hurk BM, et al. Origin of neointimal endothellum and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis [J]. J Clin Invest, 2001, 107 (11) : 1 411-422.
  • 10Shimizu K, Suglyama S, Aikawa M, et al. Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy [J]. Nat Med, 2001,7(6) : 738-741.

共引文献7

同被引文献33

  • 1肖怀秋,李玉珍,林亲录.美拉德反应及其在食品风味中的应用研究[J].中国食品添加剂,2005,16(2):27-30. 被引量:88
  • 2马冠生,胡小琪,崔朝辉,李艳平,栾德春,翟凤英,孔灵芝,杨晓光.我国居民食物消费现状与特点[J].中国食物与营养,2007,13(7):4-6. 被引量:14
  • 3DAN T, van YPERSELE de STRIHOU C, MIYATA T. Advanced glycation end products inhibitor. Studies on renal disorders[M]. American Clifton: Humana Press, 2011: 389-406.
  • 4SINGH R, BARDEN A, MORI T, et al. Advanced glycation end- products: a review[J]. Diabetologia, 2001, 44: 129-146.
  • 5CONTRERAS C, NOVAKOFSKI K. Dietary advanced glycation end products and aging[J]. Nutrients, 2010, 2: 1247-1265.
  • 6URIBARRI J, CAI W, SANDU O, et al. Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects[J]. Ann N Y Acad Sci, 2005, 1043: 461-466.
  • 7KOSCHINSKY T, HE C J, MITSUHASHI T, et al. Orally absorbedreactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy[J]. Proc Natl Acad Sci USA, 1997, 94(12): 6474-6479.
  • 8KRAJCOVICOV.A-KUDL.ACKOVA. M, SEBEKOVA K, SCHINZEL R, et al. Advanced glycation end products and nutrition[J]. Physiological Research, 2002, 51 (3): 313-316.
  • 9URIBARRI J, WOODRUFF S, GOODMAN S, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet[J]. J Am Diet Assoc, 2010, 110(6): 911-916.
  • 10GOLDBERG T, CAI W, PEPPA M, et al. Advanced glycoxidation end products in commonly consumed foods[J]. J Am Diet Assoc, 2004, 104(8): 1287-1291.

引证文献2

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部